Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: six-month analysis
- 1 January 2002
- journal article
- abstracts
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (1) , 55
- https://doi.org/10.1016/s1053-2498(01)00435-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: